2021
Four Human Cases of Eastern Equine Encephalitis in Connecticut, USA, during a Larger Regional Outbreak, 2019 - Volume 27, Number 8—August 2021 - Emerging Infectious Diseases journal - CDC
Brown SC, Cormier J, Tuan J, Lier AJ, McGuone D, Armstrong PM, Kaddouh F, Parikh S, Landry ML, Gobeske KT. Four Human Cases of Eastern Equine Encephalitis in Connecticut, USA, during a Larger Regional Outbreak, 2019 - Volume 27, Number 8—August 2021 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2021, 27: 2042-2051. PMID: 34289334, PMCID: PMC8314835, DOI: 10.3201/eid2708.203730.Peer-Reviewed Original ResearchSARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC
Ehrlich HY, Harizaj A, Campbell L, Colt M, Yuan K, Rabatsky-Ehr T, Weinberger DM, Leung V, Niccolai LM, Parikh S. SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA - Volume 27, Number 5—May 2021 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2021, 27: 1288-1295. PMID: 33900171, PMCID: PMC8084507, DOI: 10.3201/eid2705.204936.Peer-Reviewed Original ResearchConceptsPoint prevalence surveyNursing homesInfectious Diseases journal - CDCPublic health surveillance dataInfection prevention measuresNursing home staffSARS-CoV-2Health surveillance dataPoisson regression modelsCommunity incidenceIncidence ratePrevalence surveyHome staffInfectious personsCoronavirus diseaseInfection statusOutbreak controlSurveillance dataPrevention measuresIncidenceRegression modelsDisease spreadStaffHomeResidentsEffectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021
Britton A, Slifka K, Edens C, Nanduri SA, Bart S, Shang N, Harizaj A, Armstrong J, Xu K, Ehrlich HY, Soda E, Derado G, Verani JR, Schrag SJ, Jernigan JA, Leung VH, Parikh S. Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021. MMWR Morbidity And Mortality Weekly Report 2021, 70: 396-401. PMID: 33735160, PMCID: PMC7976620, DOI: 10.15585/mmwr.mm7011e3.Peer-Reviewed Original ResearchConceptsPfizer-BioNTech COVID-19 vaccineSkilled nursing facilitiesCOVID-19 vaccineLong-term care facilitiesSNF residentsNursing facilitiesCOVID-19 vaccine clinical trialsCOVID-19-associated morbidityEarly COVID-19 vaccinationSARS-CoV-2 infectionElectronic chart reviewVaccine effectiveness dataUnderlying medical conditionsVaccine clinical trialsCOVID-19 vaccinationPfizer-BioNTech vaccineSARS-CoV-2Long-term care programsStaff membersChart reviewFirst doseVaccination statusPartial vaccinationVaccine impactSecond dose
2020
Point Prevalence Testing of Residents for SARS-CoV-2 in a Subset of Connecticut Nursing Homes
Parikh S, O’Laughlin K, Ehrlich HY, Campbell L, Harizaj A, Durante A, Leung V. Point Prevalence Testing of Residents for SARS-CoV-2 in a Subset of Connecticut Nursing Homes. JAMA 2020, 324: 1101-1103. PMID: 32790860, PMCID: PMC7418038, DOI: 10.1001/jama.2020.14984.Peer-Reviewed Original ResearchConceptsConnecticut nursing homesAcute respiratory syndrome coronavirus 2 infectionNursing homesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionSyndrome coronavirus 2 infectionCoronavirus 2 infectionPolymerase chain reaction testSARS-CoV-2Chain reaction testPoint prevalenceReaction testInfectionPrevalenceResidents